Millot, Frédéric

Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. [electronic resource] - European journal of cancer (Oxford, England : 1990) Dec 2014 - 3206-11 p. digital

Publication Type: Journal Article

1879-0852

10.1016/j.ejca.2014.10.007 doi


Adolescent
Antineoplastic Agents--adverse effects
Benzamides--adverse effects
Body Height--drug effects
Body Mass Index
Child
Child, Preschool
Female
Growth Disorders--chemically induced
Humans
Imatinib Mesylate
Infant
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Piperazines--adverse effects
Pyrimidines--adverse effects
Retrospective Studies